BGI Genomics

BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by a wealth of peer-reviewed publications in prestigious

BGI Genomics      [2022-04-22 17:01:07 ]

BGI Genomics H1 Revenues Fall 11 Percent on COVID-19 Testing Decline

NEW YORK – Chinese diagnostics firm BGI Genomics reported last week that its H1 2021 revenues declined 11 percent due to decreasing demand for COVID-19 testing. Total revenues were RMB 3.6 billion ($560 million), down from RMB 4.1 billion in the same period last year. The firm\

BGI Genomics      [2022-04-22 17:00:42 ]

BGI Genomics Sees Diagnostics Core Business Rebounding, Overseas Business Growing

NEW YORK – BGI Genomics has seen growth in several areas of its core diagnostic testing business during the first half of 2021 and is working on upgrading its tests in reproductive health. Late last month, the publicly traded clinical BGI gene test and research services arm of

BGI Genomics      [2022-04-22 17:00:14 ]

The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing

Introduction The sequencing-based noninvasive BGI prenatal test has been successfully integrated into clinical practice and facilitated the early detection of fetal chromosomal anomalies. However, a comprehensive reference material to evaluate and quality control NIPT services fr

BGI Genomics      [2022-04-22 16:59:51 ]

Global Non-Invasive Prenatal Testing (NIPT) Market 2020-2031: Focus on Method, Test, Platform, End-user, Application and Country - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The \"Global Non-Invasive BGI prenatal test Market Focus on Method, Test, Platform, End User, Application and Country Analysis and Forecast, 2020-2031\" report has been added to ResearchAndMarkets com\'s offering. The global NIPT market was valued at $2.5

BGI Genomics      [2022-04-22 16:59:26 ]

BGI Genomics, Genoks Team to Expand Genetic Testing in Turkey

BGI Genomics and the Turkish genomics healthcare company Genoks have inked a new memorandum of understanding (MOU) broadening their existing partnership in the field of noninvasive BGI prenatal test. The updated MOU commits BGI Genomics to provide full technical and strategic sup

BGI Genomics      [2022-04-22 16:58:58 ]

Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA

Abstract of BGI prenatal test Objectives The aim of this study was to assess the performance of noninvasively prenatal testing (NIPT) for fetal copy number variants (CNVs) in clinical samples, using a whole-genome sequencing method. Method A total of 919 archived maternal plasma

BGI Genomics      [2022-04-22 16:58:30 ]

The Nifty Test for Pregnant Women: Non-Invasive Prenatal Testing

At BGI there aim is to apply their high genetic research capacity and well-developed global network to solving current health issues worldwide. They are committed to raising genetic health awareness and reducing the rate of major disease by offering a broad array of accurate, rel

BGI Genomics      [2022-04-22 16:58:04 ]

Noninvasive prenatal diagnosis of hemophilia A by a haplotype-based approach using cell-free fetal DNA

Abstract of BGI prenatal test Aim We aimed to demonstrate noninvasive prenatal diagnosis (NIPD) of hemophilia A (HA) using a haplotype-based approach. Methods Two families at risk for HA were recruited for this study. First, maternal haplotypes associated with pathogenic variants

BGI Genomics      [2022-04-22 16:57:41 ]

BGI is granted patent in 16 countries for non-invasive prenatal genetic test technology

Patent for non-invasive BGI prenatal test granted by European Patent Office and State Intellectual Property Office of China October 10, 2014, Shenzhen, China-- The European Patent Office has issued patent number EP2561103B1 for invention to BGI for its independently researched no

BGI Genomics      [2022-04-22 16:57:17 ]

Genomic Analyses from Non-invasive Prenatal Testing Reveal Genetic Associations, Patterns of Viral Infections, and Chinese Population History

We analyze whole-genome sequencing data from 141,431 Chinese women generated for non-invasive BGI prenatal test (NIPT). We use these data to characterize the population genetic structure and to investigate genetic associations with maternal and infectious traits. We show that the

BGI Genomics      [2022-04-22 16:56:54 ]

About BGI

BGI, founded in 1999 with the vision of using genomics to benefit the human race, is now the world’s largest genomics organisation. BGI includes both private non-profit research institutes and sequencing application commercial units. Together with its affiliated offshoots, BGI

BGI Genomics      [2022-04-22 16:56:29 ]

China's BGI and Huawei partner on Big Data genomic system storage

BGI China High-profile China genomic sequencing company BGI and telecom network manufacturer and services company Huawei Technology plan a massive data-storage system for genomic research to achieve \"an over 30% improvement in the overall efficiency of genome sequencing research

BGI Genomics      [2022-04-22 16:56:08 ]

Bgi Genomics Co., Ltd.

Overview of BGI China Doing Business As Bgi Genomics Co., Ltd. Company Description Bgi Genomics Co., Ltd. is located in Shenzhen, Guangdong, China and is part of the Scientific Research and Development Services Industry. Bgi Genomics Co., Ltd. has 3,778 total employees across all

BGI Genomics      [2022-04-22 16:55:40 ]

China's gene-sequencing giant BGI to join UAE genome project

BGI China China\'s top gene-sequencing provider BGI will participate in the Genome Program, which aims to use genomic data to improve health outcomes in the United Arab Emirates (UAE), the company announced Wednesday. The program plans to use large-scale genomic data to establish

BGI Genomics      [2022-04-22 16:55:07 ]

A Chinese Genome Giant Sets Its Sights on the UItimate Sequencer

THE WORLD’S LARGEST genetics research center isn’t at Harvard or Stanford or even the NIH. It’s a 20-mile drive from Hong Kong International Airport, in the bustling Chinese city of Shenzhen. BGI (BGI China)---formerly the Beijing Genomics Institute---has sequenced the DNA

BGI Genomics      [2022-04-22 16:54:43 ]

BGI: China meets Europe in the Baltics

BGI China “An attractive and dynamic business climate for high value-added products – indeed, that is what we see in Latvia.” BGI, one of the world’s largest genomics organizations, is a striking example of how LIAA attracts foreign investment and successful companies to

BGI Genomics      [2022-04-22 16:54:18 ]

Roundup: China's biotech giant BGI opens COVID-19 test kit plant in Ethiopia

BGI China ADDIS ABABA, Sept. 22 (Xinhua) -- Chen Songheng, General Manager of BGI Ethiopia, a subsidiary company of China\'s biotech giant, BGI Genomics Co., Ltd., is feeling optimistic about Ethiopia\'s anti-COVID-19 fight. Chen administers the Chinese company\'s first ever plan

BGI Genomics      [2022-04-22 16:53:51 ]

Beijing Genomics Institute (BGI)

BGI ((BGI China) was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI has

BGI Genomics      [2022-04-22 16:53:25 ]

Beijing Genomics Institute (BGI)

BGI / BGI China (formerly known as Beijing Genomics Institute ) was founded in Beijing on Sept 9th, 1999 with the mission of supporting the development of science and technology, building strong research teams, and promoting the development of scientific partnership in genomics f

BGI Genomics      [2022-04-22 16:53:03 ]